168 related articles for article (PubMed ID: 8284263)
1. Conformational analysis of synthetic peptides encompassing the factor XI and prekallikrein overlapping binding domains of high molecular weight kininogen.
You JL; Page JD; Scarsdale JN; Colman RW; Harris RB
Peptides; 1993; 14(5):867-76. PubMed ID: 8284263
[TBL] [Abstract][Full Text] [Related]
2. Calorimetric and spectroscopic examination of the solution phase structures of prekallikrein binding domain peptides of high molecular weight kininogen.
You JL; Scarsdale JN; Harris RB
J Protein Chem; 1991 Jun; 10(3):301-11. PubMed ID: 1910462
[TBL] [Abstract][Full Text] [Related]
3. Solution phase conformation studies of the prekallikrein binding domain of high molecular weight kininogen.
Scarsdale JN; Harris RB
J Protein Chem; 1990 Oct; 9(5):647-59. PubMed ID: 2085389
[TBL] [Abstract][Full Text] [Related]
4. Localization of the binding site on plasma kallikrein for high-molecular-weight kininogen to both apple 1 and apple 4 domains of the heavy chain.
Page JD; You JL; Harris RB; Colman RW
Arch Biochem Biophys; 1994 Oct; 314(1):159-64. PubMed ID: 7944388
[TBL] [Abstract][Full Text] [Related]
5. Structures of factor XI and prekallikrein bound to domain 6 of high-molecular weight kininogen reveal alternate domain 6 conformations and exosites.
Li C; Barroeta AB; Wong SS; Kim HJ; Pathak M; Dreveny I; Meijers JCM; Emsley J
J Thromb Haemost; 2023 Sep; 21(9):2378-2389. PubMed ID: 37068593
[TBL] [Abstract][Full Text] [Related]
6. Physical and biological significance of peptide sequences mediating the interaction between high molecular weight kininogen and plasma prekallikrein.
Colman RW; Lin Y; Yan WY; McCrae KR; Shenoy SS; Harris RB
Immunopharmacology; 1997 Jun; 36(2-3):193-200. PubMed ID: 9228546
[TBL] [Abstract][Full Text] [Related]
7. Direct evidence for multifacial contacts between high molecular weight kininogen and plasma prekallikrein.
Lin Y; Shenoy SS; Harris RB; Colman RW
Biochemistry; 1996 Oct; 35(39):12945-9. PubMed ID: 8841140
[TBL] [Abstract][Full Text] [Related]
8. Primary structure requirements for the binding of human high molecular weight kininogen to plasma prekallikrein and factor XI.
Tait JF; Fujikawa K
J Biol Chem; 1987 Aug; 262(24):11651-6. PubMed ID: 3650269
[TBL] [Abstract][Full Text] [Related]
9. Mapping of the H-kininogen binding site exposed by the prekallikrein heavy chain.
Herwald H; Hock H; Jahnen-Dechent W; Müller-Esterl W
Agents Actions Suppl; 1992; 38 ( Pt 1)():225-32. PubMed ID: 1466274
[No Abstract] [Full Text] [Related]
10. Mapping of the high molecular weight kininogen binding site of prekallikrein. Evidence for a discontinuous epitope formed by distinct segments of the prekallikrein heavy chain.
Herwald H; Jahnen-Dechent W; Alla SA; Hock J; Bouma BN; Müller-Esterl W
J Biol Chem; 1993 Jul; 268(19):14527-35. PubMed ID: 7686159
[TBL] [Abstract][Full Text] [Related]
11. The shape of high molecular weight kininogen. Organization into structural domains, changes with activation, and interactions with prekallikrein, as determined by electron microscopy.
Weisel JW; Nagaswami C; Woodhead JL; DeLa Cadena RA; Page JD; Colman RW
J Biol Chem; 1994 Apr; 269(13):10100-6. PubMed ID: 8144509
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the H-kininogen-binding site on factor XI: a comparison of factor XI and plasma prekallikrein.
Renné T; Gailani D; Meijers JC; Müller-Esterl W
J Biol Chem; 2002 Feb; 277(7):4892-9. PubMed ID: 11733491
[TBL] [Abstract][Full Text] [Related]
13. Studies of binding of prekallikrein and Factor XI to high molecular weight kininogen and its light chain.
Thompson RE; Mandle R; Kaplan AP
Proc Natl Acad Sci U S A; 1979 Oct; 76(10):4862-6. PubMed ID: 291905
[TBL] [Abstract][Full Text] [Related]
14. Mapping of the discontinuous kininogen binding site of prekallikrein. A distal binding segment is located in the heavy chain domain A4.
Herwald H; Renné T; Meijers JC; Chung DW; Page JD; Colman RW; Müller-Esterl W
J Biol Chem; 1996 May; 271(22):13061-7. PubMed ID: 8662705
[TBL] [Abstract][Full Text] [Related]
15. The role of high molecular weight kininogen and prothrombin as cofactors in the binding of factor XI A3 domain to the platelet surface.
Ho DH; Badellino K; Baglia FA; Sun MF; Zhao MM; Gailani D; Walsh PN
J Biol Chem; 2000 Aug; 275(33):25139-45. PubMed ID: 10823824
[TBL] [Abstract][Full Text] [Related]
16. Binding of high-molecular-mass kininogen to the Apple 1 domain of factor XI is mediated in part by Val64 and Ile77.
Seaman FS; Baglia FA; Gurr JA; Jameson BA; Walsh PN
Biochem J; 1994 Dec; 304 ( Pt 3)(Pt 3):715-21. PubMed ID: 7818472
[TBL] [Abstract][Full Text] [Related]
17. Mapping of the prekallikrein-binding site of human H-kininogen by ligand screening of lambda gt11 expression libraries. Mimicking of the predicted binding site by anti-idiotypic antibodies.
Vogel R; Kaufmann J; Chung DW; Kellermann J; Müller-Esterl W
J Biol Chem; 1990 Jul; 265(21):12494-502. PubMed ID: 1695630
[TBL] [Abstract][Full Text] [Related]
18. Localization of the high molecular weight kininogen binding site in the heavy chain of human factor XI to amino acids phenylalanine 56 through serine 86.
Baglia FA; Jameson BA; Walsh PN
J Biol Chem; 1990 Mar; 265(7):4149-54. PubMed ID: 2105959
[TBL] [Abstract][Full Text] [Related]
19. The contact activation proteins: a structure/function overview.
Meijers JC; McMullen BA; Bouma BN
Agents Actions Suppl; 1992; 38 ( Pt 2)():219-30. PubMed ID: 1462829
[TBL] [Abstract][Full Text] [Related]
20. Factor XI binding to activated platelets is mediated by residues R(250), K(255), F(260), and Q(263) within the apple 3 domain.
Ho DH; Baglia FA; Walsh PN
Biochemistry; 2000 Jan; 39(2):316-23. PubMed ID: 10630991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
